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Abstract
Background: Cryptococcus neoformans causes serious disease in immunocompromised individuals, leading to over 600,000
deaths per year worldwide. Part of this impact is due to the organism’s ability to thwart what should be the mammalian
hosts’ first line of defense against cryptococcal infection: internalization by macrophages. Even when C. neoformans is
engulfed by host phagocytes, it can survive and replicate within them rather than being destroyed; this ability is central in
cryptococcal virulence. It is therefore critical to elucidate the interactions of this facultative intracellular pathogen with
phagocytic cells of its mammalian host.
Methodology/Principal Findings: To accurately assess initial interactions between human phagocytic cells and fungi, we
have developed a method using high-throughput microscopy to efficiently distinguish adherent and engulfed cryptococci
and quantitate each population. This method offers significant advantages over currently available means of assaying host-
fungal cell interactions, and remains statistically robust when implemented in an automated fashion appropriate for
screening. It was used to demonstrate the sensitivity of human phagocytes to subtle changes in the cryptococcal capsule, a
major virulence factor of this pathogen.
Conclusions/Significance: Our high-throughput method for characterizing interactions between C. neoformans and
mammalian phagocytic cells offers a powerful tool for elucidating the relationship between these cell types during
pathogenesis. This approach will be useful for screens of this organism and has potentially broad applications for
investigating host-pathogen interactions.
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Introduction
Cryptococcus neoformans is an opportunistic fungal pathogen of
mammals, which causes life-threatening illness in severely
immunocompromised hosts. Inhalation of the infectious particle
results in a primary pulmonary infection that can lead to a fatal
meningitis [1]. Cryptococcosis affects close to one million people
annually and kills over 600,000 of them, mainly in sub-Saharan
Africa [2]. This virulence is mediated by multiple factors, but
prominent among them is the ability to form an anti-phagocytic
polysaccharide capsule [3].
The first step of cryptococcal infection occurs when a
mammalian host inhales the infectious particles, which are of a
size that allows them to reach the alveoli. Fungi can then persist
and replicate in the alveolar spaces, or they may encounter host
macrophages and become internalized [4–6]. These infected
macrophages may remain in the lungs or leave the pulmonary
system, allowing fungal dissemination. Once within macrophages,
there are several possible fates for C. neoformans. The fungus can
exit the macrophage by causing host cell lysis. Alternatively, it can
remain sequestered within the host cell, where it can either
continue to replicate or potentially exist in a latent form until
reactivation in the setting of immune compromise [7–9]. The
fungus may also be killed by the macrophage, or exit the host cell
through an intriguing non-lytic mechanism that may also allow
direct transfer between host cells [10–13]. Understanding the
interactions between mammalian host macrophages and C.
neoformans is key to explaining successful fungal pathogen
dissemination, latency, and host damage [14–18].
Host-microbe interactions at the cellular level can be investi-
gated in multiple ways [19–22]. We have used microscopy to
quantitate the initial interactions between C. neoformans and host
cells: cell adherence and fungal internalization. Although direct
imaging of these events may be possible in some model organisms
that have been used to study cryptococcal infection, such as
Caenorhabditis elegans [20], we have chosen to assay cells in culture to
facilitate automation and high-throughput approaches. Multiple
systems have been used to study fungal engulfment by phagocytes
in culture, ranging from single celled organisms like Acanthamoeba
and Dictyostelium to cell lines derived from Drosophila, mouse, and
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performed in murine cell lines, we chose human cell lines as the
phagocytic partner in our assay because of the significant human
disease caused by this organism.
A variety of methods have been used to quantitate in vitro studies
of interactions between intracellular pathogens and host cells.
Some of these measure total pathogens associated with host cells:
for example by exposing host cells to the infecting microbe,
washing them, and then assessing associated colony forming units
(CFU) [23]; or by using flow cytometry to sort host cells exposed to
fluorescent microbes [24,25]. Although these methods are useful,
they generally do not differentiate between adherent and
internalized organisms, which are distinct populations in terms
of host interactions. One approach to specifically assessing
internalized microbes is to add a non-membrane permeant drug
to the assay, such that adherent microbes are killed and therefore
not viable in CFU assays [26–28]. While extremely powerful [29],
this method does not allow direct measurement of adherent cells.
For directly measuring both adherent and internalized microbes,
judicious use of fluorescent staining in conjunction with light
microscopy has been most effective [30,31]; we have applied such
an approach below.
Fungal pathogens are an emerging threat for which we have a
limited toolbox. These pathogens are evolving rapidly, and
severely affect both immunocompromised and immunocompetent
individuals [2,32–36]. We have established a new, fast, and
accurate method for studying the initial interactions of C.
neoformans cells with host macrophages. This method offers a
powerful approach to understanding cryptococcal biology and has
potential application to other pathogens.
Results
Assay development
Our goal was to develop a rapid and effective method to
differentiate between adherent and engulfed cells after in vitro
exposure of host cells to C. neoformans, and to quantitate each
population. We began with a mouse macrophage-like cell line,
J774.16, which has been extensively evaluated for interactions with
C. neoformans. To assess adherence and internalization, we first
tested a strategy that has been effective in C. neoformans [37–39]
and other eukaryotic pathogens [40]: performing antibody
labeling before and after host cell permeabilization. To do this
we exposed host cells to serum-opsonized C. neoformans cells, and
then stained the samples with an anticapsular monoclonal
antibody (3C2 [41], generously provided by T. Kozel) to identify
cryptococci that only attach to the host cell surface (Fig. 1A). We
next washed the samples, permeabilized the host cells with
saponin, and restained the samples using the same antibody tagged
with a second fluorophore to label all cryptococci associated with
the host cells (Fig. 1B). As shown in the merged image (Fig. 1C;
which also shows a DIC image and DAPI-staining of the J774.16
cells), a doubly-labeled adherent yeast (yellow) is clearly distin-
guishable from the internalized cells that are only labeled with the
second fluorophore (green). While this method was clearly
effective, and could be scored by automated microscopy (not
shown), it requires multiple staining steps and relies on a biological
reagent that is organism-specific and not commercially available.
For these reasons we considered other methods for identifying
fungal cells.
We had previously observed that Lucifer Yellow dye uniformly
stains cryptococcal cell walls without affecting cell morphology or
subsequent growth in culture (A. Yoneda and T.L. Doering,
unpublished observations). This staining is rapid, inexpensive, and
commercially available. Before applying this reagent to our
studies, however, we needed to be sure that this staining did not
adversely affect the fungal cells in terms of their host interactions.
To test this, we performed sequential antibody labeling studies (as
in Fig. 1A–C) using fungi with or without prior Lucifer Yellow
staining. Staining of the fungi before host cell exposure did not
alter adherence and uptake as measured by this assay (Table S1).
We next tested Lucifer Yellow-stained cryptococci in a mouse
model of infection (see Methods). We found that the stained fungal
cells were able to proliferate in the mouse lungs to the same degree
as the untreated fungal cells (Fig. 2; p value=0.37), suggesting that
the dye caused no significant alteration in their host interactions or
growth.
Based on our results in tissue culture and in mice, we used
Lucifer Yellow-stained cryptococci to assay interactions with
THP-1, a human monocytic cell line [42,43] that has been used
Figure 1. Distinguishing adherent and internalized cryptococci. Panels A–C, J774.16 cells were exposed to fungi labeled with anti-capsular
mAb and adherent fungi were labeled with an Alexa Fluor 546-labeled secondary antibody (red). Host cells were then permeabilized, and the samples
were restained with an Alexa Fluor 488-labeled secondary antibody to stain all fungi (green). Panel A, red channel; Panel B, green channel; Panel C,
merge with DIC and DAPI-stained images. Panels D–E, Confocal images of THP-1 cells were challenged for 1 hr with Lucifer Yellow-stained fungi and
stained with CellMask (pink). All fungi appear green in the merged image (D), but only engulfed fungi exclude the cytosolic dye and appear as dark
silhouettes in the pink channel (E). Scale bars, 5 mm.
doi:10.1371/journal.pone.0022773.g001
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47]. We exposed THP-1 derived macrophages to Lucifer Yellow-
stained fungi, washed them with PBS to remove non-adherent
cells, and then stained the host cytosol with CellMask. As shown
by confocal fluorescent imaging (Fig. 1D), both cell types are easily
visualized, and the displacement of the cytosolic dye by
internalized fungi (Fig. 1E) allows those that have been engulfed
(seen as silhouettes in the host cytosol) to be readily distinguished
from those that are adherent to the host cell surface. We also
analyzed assay samples in parallel using this method or the method
described above that is based on antibody staining before and after
host cell permeabilization. The results from the two methods were
indistinguishable (not shown).
While developing our assay, we observed that fungi interacted
more extensively with THP-1 cells than with J774.16 (Fig. 3A). To
quantitate this result and explore additional host lines, we
compared the interactions between C. neoformans and J774.16,
THP-1, RAW 264.7 (a murine macrophage-like cell line [48]), and
U937 (a human monocytic cell line [49]). All of these cell lines
share characteristics important for our assay: they display
receptors involved in the complement pathway (known to be
important in cryptococcal infection [50–53]), and they have
phagocytic capabilities. In a direct comparison we found that
THP-1 cells were most active in our assay (Fig. 3B), so we used this
human cell line for all subsequent studies.
Automated imaging and assay kinetics
Our studies up to this point were analyzed manually, with
visualization by conventional fluorescence microscopy. While this
method yielded clear and reproducible results, we wished to
automate our assays to reduce the time required for analysis. To
do this we took advantage of automated high-content imaging,
after first scaling our assay up to 96-well microtiter plate format.
As in the earlier studies, we challenged host cells with Lucifer
Yellow-stained cryptococci, then fixed and stained the samples
with DAPI and CellMask. We next imaged the wells with a GE
INCell Analyzer, using individual channels to visualize Lucifer
Yellow-stained fungi (Fig. 4A), DAPI-stained host nuclei (Fig. 4B),
and CellMask-stained host cytosol (Fig. 4C). The relationship
between these stains is clearly seen in a merged image of a
representative assay (Fig. 4D). Finally, we used an automated
developer to identify each stained entity (Fig. 4E), and to classify
each fungal cell in terms of its relationship to the host cells. We
defined adherent cells as those where signal overlap with a host cell
was greater than 1% and less than 50%, and engulfed cells as those
where the overlap was equal to or greater than 50%, recording all
results on an individual cell basis to allow flexible analysis. We
recognize that this classification may not always be precise because
of cell positions in the imaging field, but parallel manual inspection
(including examination of multiple focal planes) yielded results that
were statistically indistinguishable (Table S2). This suggests that
we have developed a robust and biologically meaningful assay.
Having established a reliable assay with automated analysis, we
used it to characterize various experimental parameters. Among
these we noted a linear relationship between the number of
cryptococcal cells added to each host well and their adherence or
uptake by the phagocytes, up to a ratio of at least 1:1 (Fig. 5A). We
also performed a time course study to examine the kinetics of
interactions with the host cells. We found that adherence begins to
level off close to 30 minutes after exposure, while uptake does not
begin to plateau until significantly later (Fig. 5B; see Discussion).
Biological and statistical assay validation
We next wanted to apply our assay to a feature of C. neoformans
with known biological relevance to phagocyte interactions. The
cryptococcal capsule, mentioned above as a major virulence factor
of this pathogen, is known to be antiphagocytic [53–56]. Capsule
size increases during growth in various inducing media, including
the ‘host-like’ conditions of growth in mammalian tissue culture
medium at 37uC in a 5% CO2 atmosphere. Enlarged capsule can
be readily observed as a halo surrounding the cell wall upon
negative staining with India ink (Fig. 6B), and is typically visible by
such staining after 4–8 hours in inducing conditions (not shown).
We grew cells in parallel under these inducing conditions or in the
same medium at 37uC but in room air (which does not yield
Figure 2. Lucifer Yellow does not alter cryptococcal survival in
mouse lung. Mice were infected with fungal cells treated without
(standard) or with Lucifer Yellow. Lungs were harvested for CFU counts
at 1 hour (yellow bars) or 1 week (blue bars) after infection. Mean and
standard deviation of values are shown.
doi:10.1371/journal.pone.0022773.g002
Figure 3. Host lines differ in phagocytosis of C. neoformans.
Panel A, bright-field microscopy of J774.16 and THP-1 cells challenged
with fungi. All fungal cells shown were internalized except one (yellow
arrowhead). Scale bar, 5 mm. Panel B, adherence (yellow bars) and
uptake (blue bars) values for the indicated macrophage-like cell lines.
Mean and standard deviation values are shown.
doi:10.1371/journal.pone.0022773.g003
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time points for testing in our assay. We saw reduced adherence as
early as 1 hour after the start of capsule induction (Fig. 6C), a time
point at which changes in capsule size are not visible by India ink
staining (not shown). Both adherence and uptake were almost
completely repressed in capsule induced samples by 24-hours
(Fig. 6C and data not shown), a time point at which uptake and
adherence of uninduced samples is still robust.
The experiments described above, including the capsule
induction study, demonstrated that our automated assay is rapid
and sensitive to cellular features of biological significance,
suggesting it will be appropriate for large-scale screening projects.
For such studies, however, it is necessary to statistically
characterize and validate the assay. To do this, we assayed sets
of 96-well plates in triplicate using unopsonized and opsonized
cryptococcal cells as negative and positive control conditions,
respectively (Fig. 7). We then evaluated our assay with two
different statistical measures, Z factor [57] and SSMD (strictly
standardized mean difference [58–60]). Z factor compares the
variation in average assay values for positive and negative controls
to the difference between those values, and is best applied to
studies in which a normal distribution of data is expected. We
routinely observed Z factor scores between 0.5 and 1, indicating
an excellent screening assay, appropriate for high-throughput
studies. SSMD relates the difference between the mean values of
two control populations to the standard deviation of the difference
between them [58], and is more robust to variation in data ranges
(outliers) and to data variability. Our calculated SSMD scores
were typically above 3 (Table S3), which, like the results for Z-
factor, demonstrate that the assay is appropriate for high-
throughput screening.
Discussion
Central features of cryptococcal pathogenesis, including dis-
semination, latency, and host cell damage, depend upon the
interactions between Cryptococcus neoformans cells and mammalian
phagocytes. Screening approaches are potentially powerful for
elucidating these processes. However, current ways to assess
fungal-host cell interactions, such as protocols that rely on low-
throughput imaging techniques and limited reagents [37,61], are
not ideal for screens. To enable efficient screening of interactions
between C. neoformans and host phagocytes, we have applied high-
content automated microscopy and analysis. This allows us to
assess the initial interactions of Cryptococcus neoformans with
mammalian host macrophages in a high-throughput manner.
A key parameter in this work was the choice of host cell type, so
we investigated the uptake and adherence indices of four
macrophage/macrophage-like cell lines, ultimately choosing the
human THP-1 cell line for our assay. Although most studies of C.
neoformans have used mouse lines such as J774.16, we chose to work
within the human system, using both human serum and a human
cell line. THP-1 cells may be readily differentiated into
macrophage-like cells in culture and demonstrate a high
phagocytic capability in our assay, even without activation by
antibodies or LPS (which have been frequently used for
cryptococcal uptake studies). Importantly, these cells display Fc
and C3 receptors, which play roles in pathogen recognition; the
latter are particularly important for recognition of the cryptococcal
capsule [50]. We have validated the biological sensitivity of THP-1
cells to C. neoformans by our demonstration that they can detect
alterations in capsule within less than two hours of capsule
induction by ‘host-like’ conditions.
Our protocol readily distinguishes between adherent and
engulfed cryptococci in an efficient and cost-effective manner. It
requires fewer manipulations than antibody-based protocols,
reducing cell loss as well as effort and reagents. The method
directly images the particles of interest, in contrast to studies that
use antibodies or quenching [23] to calculate pathogen distribu-
tion based on differences in signal. Importantly, this assay may also
be readily adapted to multiple cell types by using widely available
stains to label the host nuclei and cytosol as well as the
cryptococcal cells. The ability to simultaneously track adherent
and internalized cells has allowed us to observe differences in the
kinetics of appearance of these populations (Fig. 5). These results
suggest that adherence precedes internalization, as might be
expected, and further that these processes may be saturable. The
ability to differentiate between bound and internalized popula-
tions, which is not currently possible with other high-throughput
assays, allows us to study these distinct steps independently.
The largely automated protocol we have developed has multiple
technical advantages. Up to eighty samples plus controls can be
screened simultaneously in 96-well format, and higher density
formats offer promising preliminary results (not shown). Our
statistical analysis reveals consistent results across and within
multiple plates, and the assay is appropriate for high-throughput
screening based on two different statistical parameters (Z factor
Figure 4. Automated fluorescent microscopy and segmenta-
tion analysis. Uptake of Lucifer yellow-stained fungal cells by THP-1
cells was performed as described in Methods. Panels A–C, cryptococcal
cells imaged by Lucifer Yellow (A), host nuclei imaged with DAPI (B),
and host cytosol imaged by CellMask (C). Panel D, fused image of Panels
A–C. Panel E, the image in panel D automatically annotated to indicate
boundaries of host cells (red), host cell nuclei (turquoise), and fungi
(green). Fungal cells overlapping the cell body by less than 50% are
considered adherent (yellow arrow) and those overlapping by $50%
are considered engulfed (white arrow). The fungal cell at upper left
appears pale because it overlies the host nucleus. Scale bars, 10 mm.
doi:10.1371/journal.pone.0022773.g004
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associated with microscopy based assays by using automated
imaging, and the high-content images generated in this way are
rich in information which can be mined for additional phenotypic
details. We have validated the method through the use of different
cell types, both host (Fig. 2) and pathogen (not shown), and the
data quality matches that of the ‘‘gold standard’’ method of using
manual inspection of antibody-labeled samples (Table S2). Finally,
our automated collection of data on individual host and fungal
cells offers great flexibility in terms of analysis.
Cryptococcus neoformans is a successful fungal pathogen. Much of
this is due to its ability to produce capsule polysaccharides, which
impede host defenses including phagocytic cell deployment and
phagocytosis. Multiple aspects of the latter process may be studied
using variations of our assay. For example, we have an excellent
vantage point for the initial stages of host cell entry, which also
avoids the potential complication of fungal growth. We can change
that view by altering the time from our current one hour exposure,
potentially using shorter co-incubations to study the earliest
fungal-host cell interactions. Similarly, we can use later time points
Figure 5. Effects of cell ratio and exposure time on adherence and uptake. Indices of adherence (open circle) and uptake (closed circle) vary
with the number of fungal cells added per well (A) and with time (B). Mean and standard deviation are plotted (some error bars are too small to see).
doi:10.1371/journal.pone.0022773.g005
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replication [36] or fungal cell expulsion [10,11]. We can also
examine perturbation of the fungal-host interactions by assessing
the effects on this assay of introducing cryptococcal mutants,
down-regulating host genes, or adding various drugs. Together,
this assay and these variations will increase our understanding of
key events in cryptococcal pathogenesis.
Materials and Methods
Ethics Statement
All animal protocols were conducted following the guidelines
found in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health and were approved by
Washington University School of Medicine DCM (#20080269).
All efforts were made to minimize animal suffering.
Yeast cell growth and conditions
C. neoformans strain H99 (cultured from the ATCC C. neoformans
deletion collection, #208821) was grown in YPD broth (1% Yeast
extract, 2% peptone and 2% dextrose) and maintained at 30uCo n
YPD plates containing 2% agar. To induce capsule formation,
cultures were grown overnight from single colonies in YPD and
the cells were harvested and washed in DMEM (Sigma). The cell
density was measured using a hemocytometer and the culture was
diluted in DMEM to 1.2610
7/ml in a tissue culture flask. The
flasks were incubated at 37uC in a 5% CO2 incubator to induce C.
neoformans capsule formation or in room air for control cultures.
Capsule formation was assessed by India ink staining as in [62].
Mammalian cells and growth conditions
All mammalian cell lines were grown and maintained at 37uC
under 5% CO2. Human monocytic cell lines THP-1 and U937
were obtained from J. Atkinson and J. Vogel, respectively, and
cultured in RPMI-1640 (Invitrogen) supplemented with 10% heat-
inactivated FBS (Gibco), 100 mg/ml penicillin and 100 U/ml
streptomycin (Pen/Strep; Gibco), 1 mM sodium pyruvate (Cell-
gro), and 48 mM b-mercaptoethanol (Fisher Scientific). Murine
macrophage-like cell lines J774.16 and RAW264.7 were obtained
from the ATCC and D. Sibley, respectively, and cultured in
DMEM (Sigma) supplemented with 10% heat-activated FBS and
Pen/Strep. Monocytic cells were passaged every two days to
maintain cell density between 1.5610
5/ml and 9610
5/ml.
Macrophage-like cells were passaged every three days.
Macrophage uptake assessed by manual counts
For manual uptake assays, freshly harvested J774.16 cells were
washed twice in DMEM, adjusted to 8.3610
5/ml in DMEM, and
300 ml aliquots of the suspension were seeded onto 12 mm
silanized coverslips (Ingen Lab) in 24-well tissue culture plates
(TPP) and incubated at 37uC/5% CO2 for 24 hours. In parallel,
overnight cultures of C. neoformans in YPD were washed twice in
PBS and adjusted to 4.2610
6/ml in PBS. 240 ml of the yeast cell
suspension were opsonized and labeled by mixing with 160 ml
human serum (from healthy volunteers, following a protocol
approved by the Washington University School of Medicine IRB),
followed by the addition of 2 mg anti-cryptococcal capsule
antibody 3C2 (from T. Kozel). After a 30 min incubation (37uC,
room air, with rotation) the cells were washed three times in PBS
and re-suspended at 3.3610
6 cells/ml in DMEM (Fig. 1).
To perform the assays, prepared J774.16 macrophages were
washed gently once with DMEM to remove non-adherent cells,
and 10
6 prepared fungal cells were added to each well. The plates
were incubated at 37uC/5% CO2 for 4 hours, washed three times
with PBS to remove excess fungal cells, fixed for 10 min on ice
with 4% formaldehyde in PBS, and washed twice with PBS. To
Figure 6. Cryptococcal host interactions are highly sensitive to
capsule induction. Upper panels, India ink staining of fungal cells at
24 h without (A) or with (B) capsule induction. Panel C, standard assay
performed with cells grown for the indicated times in the conditions
shown. Mean and standard deviation are plotted for indices of
adherence. All samples were grown at 37uC in either room air (white
bars) or 5% CO2 (blue bars).
doi:10.1371/journal.pone.0022773.g006
Figure 7. Positive and negative controls used for statistical
analysis of assay power. Standard assays were performed using the
controls shown above. Mean and standard deviation are plotted for
adherence (yellow bars) and uptake (blue bars). Representative images
for each control are shown above the bars. Scale bar, 5 mm.
doi:10.1371/journal.pone.0022773.g007
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300 ml Alexa Fluor 546-conjugated goat anti-mouse IgG antibody
(Invitrogen) in PBS (25 mg/ml final concentration) was added to
each well and the plates were incubated at 37uC/5% CO2 for
30 min and then washed three times with PBS. Macrophages were
next permeabilized by incubating for 30 min at 25uC with 300 ml
0.1% saponin in PBS, washed with PBS, and stained as before but
using 10 mg/ml Alexa Fluor 488-conjugated goat anti-mouse IgG
antibody (Invitrogen). Finally, 300 mlo f1mg/ml DAPI in PBS was
added to each well to stain macrophage nuclei and the plates were
incubated for 15 min at 25uC and washed four times with PBS.
For visualization, 10-ml drops of Prolong Gold (Invitrogen) were
placed onto microscope slides (VWR) and the coverslip from each
well of the tissue culture plate was inverted onto one drop,
incubated at 25uC overnight in the dark, and observed by
fluorescence microscopy to determine the index of adherence
(adherent fungi per 100 macrophages) and the phagocytic index
(ingested fungi per 100 macrophages). Triplicate counts were
performed on each well, samples were tested in triplicate, and each
experiment was repeated at least three times.
Automated assessment of macrophage uptake and
adherence
For automated assays using monocytic cell lines, THP-1 or
U937 cells were harvested and then induced to differentiate by
resuspension at 3.4610
5/ml in growth medium supplemented
with 0.2 mg/ml phorbol 12-myristate 13-acetate (PMA) (Sigma).
Flat-bottomed polystyrene 96-well microtiter plates (Costar) were
then seeded with 3.4610
4 cells per well, incubated at 37uC/5%
CO2 for 48 hrs, washed three times with RPMI-1640 to remove
unattached cells, and incubated for an additional 24 hours in
RPMI-1640 containing Pen/Strep and 0.2 mg/ml PMA. (It has
recently been suggested that growth with and without PMA be
extended to 3 and 5 days, respectively, to generate macrophage-
like cells which more closely resemble monocyte-derived macro-
phages [63]. We find the absolute difference between assay results
using cells differentiated by either method is below 4% (Table S4).)
For automated assays using macrophage cell lines, RAW264.7 or
J774.16 cells were harvested and washed three times in DMEM,
re-suspended in DMEM supplemented with Pen/Strep and
incubated at 37uC/5% CO2 for 24 hours.
In parallel to host cell preparation, 6610
6 C. neoformans cells
grown as above were dispensed into each well of a 96-well
microtiter plate. Cells were washed twice in PBS and once in
MacIlvaine’s buffer, pH 6.0, and then labeled by the addition of
Lucifer yellow (Sigma) in MacIlvaine’s buffer to each well
(100 mg/ml final concentration) and incubation for 30 min at
25uC with shaking on an orbital shaker (BELLCO). The labeled
cells were then washed with and resuspended in 1 ml PBS in a
1.5 ml microcentrifuge tube. For opsonization the cells were
mixed with one half volume of human serum and incubated at
37uC for 30 min with orbital shaking. Finally, the opsonized
fungal cells were washed three times with PBS and resuspended at
1.7610
6/ml in RPMI-1640 or DMEM. All uptake experiments
with this protocol were opsonized using only human serum.
To perform the assays, the prepared host cells were washed
once with RPMI-1640 or DMEM depending on cell type, the
medium was aspirated, and 100 ml of the labeled and opsonized
fungal cell suspension was added to each well. The co-inoculated
plates were incubated at 37uC/5% CO2 for 1 hour and washed
four times with PBS using an ELx405 Select CW plate washer
(BioTek; used for all washes in this paragraph). Cells were fixed as
above, washed twice with PBS, permeabilized for 20 min at 25uC
with 0.1% saponin in PBS, and washed again with PBS. The
macrophage nuclei and cytoplasm were stained for 15 min at
25uC with PBS containing 2 mg/ml DAPI and 250 ng/ml
CellMask Deep Red (both from Sigma), washed twice with PBS,
and stored in PBS containing 10 mM sodium azide at 4uC in the
dark. Plates were imaged using an IN Cell analyzer (GE
Healthcare) scanning on channels of wavelengths 360/460, 475/
535, and 620/460 (to detect DAPI, Lucifer Yellow, and CellMask,
respectively). Images were analyzed using the IN Cell Developer
Toolbox (GE Healthcare). Each sample was replicated in multiple
wells within one 96-well microtiter plate and/or one well in the
same position located on 3 separate 96-well plates. 15–20 counts
were performed on each well, and all experiments were repeated
at least twice.
Mouse infection
C. neoformans from overnight cultures in YPD were washed twice
in PBS and the pellet resuspended in MacIlvaine’s Buffer pH 6.0
at a final cell density of 1.3610
8/ml. Cells were mixed with
100 mg/ml Lucifer yellow (final concentration) or an equal volume
of sterile water (for controls), incubated at 25uC with shaking for
30 minutes, washed twice with PBS, and resuspended in PBS to a
final cell density of 2.5610
5/ml. For each cell population to be
tested, eight female C57BL/6J mice, aged 4–6 weeks, were
anesthetized with 150 ml ddH2O containing 2 mg/ml xylazine
(VEDCO) and 10 mg/ml of ketaset (Fort Dodge Animal Health)
by intraperitoneal injection and intranasally inoculated with 50 ml
of the fungal suspension (1.25610
5 cells). Mice were sacrificed at
one hour (3 animals) or one week (5 animals) post infection, and
the lungs were harvested and homogenized in 5 ml PBS. Serial
dilutions of 50 ml aliquots of the lung homogenate were spotted
onto YPD plates, incubated at 30uC overnight, and used to
calculate colony forming units (CFU) per animal. In this time
period, mice infected by this protocol exhibit no symptoms of
illness.
Supporting Information
Table S1 Cryptococcal adherence and uptake of cells without or
with prior staining with Lucifer Yellow. Adherence and uptake
were assessed by antibody staining as described in the Methods.
(XLS)
Table S2 Comparison of automated and manual counts on
control assays using Lucifer Yellow-labeled fungi and THP-1 cells.
(XLS)
Table S3 Derivation of SSMD values for control studies.
(XLS)
Table S4 Comparison of PMA-differentiation protocols for
THP-1 cells.
(XLS)
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